Microflex LT (Bruker Daltonics) and VITEK MS (bioMé rieux) are bacterial identification systems that are based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). For VITEK MS, two identification softwares, VITEK MS IVD (IVD) and SARAMIS (SARAMIS), are available. Microflex LT is equipped with MALDI Biotyper RTC software (Biotyper). Although the identification accuracy of each instrument has been compared for various bacteria, no detailed examination has been conducted for the identification accuracy of Clostridium difficile. In this report, we compared the three identification softwares for identification reproducibility in three ATCC C. difficile strains and identification accuracy in 50 clinical C. difficile isolates. The results showed 100, 91.7 and 100 % identification reproducibility accuracy of ATCC strains when examined by IVD, SARAMIS and Biotyper software, respectively. For the identification of the clinical isolates, all three softwares exhibited satisfactory identification accuracy of C. difficile. Among the 50 clinical isolates, seven showed identical toxin genotype corresponding to the exact ribotype. However, MALDI-TOF MS failed to identify them as the identical type. Based on the above results, we concluded that both types of MALDI-TOF MS reproducibly identified C. difficile; however, they are currently not suitable for typing of C. difficile clones.
INTRODUCTION
Recently, matrix-assisted laser desorption/ionization timeof-flight mass spectrometry (MALDI-TOF MS) has been attracting attention as a new method for identifying micro-organisms. MALDI-TOF MS enables the inexpensive identification of microbes within a short period of time and several reports have compared its identification accuracy with that of conventional methods (Chean et al., 2014; Coltella et al., 2013; Deng et al., 2014; Marko et al., 2012; van Veen et al., 2010; Veloo et al., 2011) . VITEK MS (bioMérieux) and Microflex LT (Bruker Daltonics) are bacterial identification systems based on MALDI-TOF MS. In regard to VITEK MS, in addition to identification using in vitro diagnosis software (IVD), identification can be achieved using SARAMIS software which is specifically designed for clinical research. In contrast, MALDI Biotyper RTC software (Biotyper) is used in Microflex LT for identification. Among obligate anaerobes, Clostridium difficile is frequently isolated and the number of infected patients has been increasing every year. Indeed, in 2002, a hypervirulent C. difficile strain (B1/NAP1/027 type) was reported in several countries (Labbé et al., 2008; McFarland, 2008) and is of significant clinical concern for potential outbreaks. Martiny et al.
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On: Thu, 27 Dec 2018 01:00:20 (2012) conducted a comparative investigation to examine the accuracy of identifying clinical isolates using three softwares with two types of MALDI-TOF MS and obtained satisfactory results with both types. However, only 11 strains of C. difficile were examined and the performance of SARAMIS was low. The use of MALDI-TOF MS for other applications is also being investigated, including toxin detection and epidemiological analyses (Barbuddhe et al., 2008; Reil et al., 2011; Rettinger et al., 2012; Siegrist et al., 2007; Williamson et al., 2008) . In this study, we conducted a comparative investigation of the reproducibility and accuracy of three identification softwares with two types of instrument. Identification reproducibility and accuracy were tested using three ATCC strains and 50 clinical isolates of C. difficile, respectively. We further examined typing comparison between the two software models.
METHODS
Bacterial isolates. C. difficile strains ATCC 9689, 43593 and BAA-1870 were used as reference strains. In total, 50 clinical isolates of C. difficile were used that had been isolated from samples of C. difficile-associated diarrhoea submitted to the Department of Clinical Laboratory and Laboratory Medicine at the Kyushu University Hospital between May and September 2011 and between April and August 2013. Isolates were biochemically identified and successfully preserved (growth confirmation on cyclosetin-cefoxitin mannitol agar, RapID ANA II System). All bacterial strains were cultured on Brucella HK agar plates (Nikken Bio Medical Laboratory) and incubated at 35 uC under anaerobic conditions for 48 h and used after two sub-passages.
MALDI-TOF MS analysis. For pre-treatment of samples, full formic extraction (EX) was performed. In EX, colonies of C. difficile were resuspended in 300 ml distille water, mixed with 900 ml 99.5 % ethanol and then vortexed. After centrifuging for 2 min at 14 000 g, 30 ml 70 % formic acid was added to the precipitates; they were fully resuspended and then 30 ml acetonitrile was added and mixed. After centrifuging for 2 min at 14 000 g, 1 ml supernatant was taken and used as a sample. To determine identification performance at the species level, the following criteria were used: IVD, 60 % or above; SARAMIS, 70 % or above; Biotyper, 2 or above. During identification performance assessment of clinical isolates, a higher score from duplicate measurements was used.
VITEK MS analysis. EX-treated samples were applied to a target plate and 1 ml a-cyano-4-hydroxycinnamic acid (CHCA) matrix solution was added before drying. Following sample drying, measurements were performed using VITEK MS in duplicate (50/60 Hz nitrogen laser, 500-800 shots per strain, measurement range 2000-20 000 m/z). The resulting spectra were analysed with identification softwares IVD (version 2.0) and SARAMIS (version 4.1). A phylogenetic tree was prepared using SARAMIS for typing.
Microflex LT analysis. EX-treated samples were applied to a 96-well target plate and 1 ml CHCA matrix solution was added before drying. After drying the CHCA matrix solution, measurements were performed using Microflex LT in duplicate (60 Hz nitrogen laser, 240-480 shots per strain, measurement range 2000-20 000 m/z). The resulting spectra were analysed with the identification software Biotyper (version 3.1). A phylogenetic tree was prepared using ClinPro Tools (version 2.2) for typing.
PCR ribotyping. Ribotyping was performed following the method of Stubbs et al. (1999) . Cultured colonies were resuspended in 50 ml sterile distilled water, heated for 12 min at 100 uC and centrifuged for 10 min at 14 000 r.p.m. The resulting supernatant was used as a DNA template. Sequences of primers used were: 59-CTGGGGTGAAGTC-GTAACA-39 (16S rRNA) and 59-GCGCCCTTTGTAGCTTGACC-39 (23S rRNA). For PCR, 2.5 ml each 25 pmol primers, 5 ml DNA template, 5 ml 10| ExTaq Buffer, 4 ml dNTP and 0.4 ml ExTaq (Takara Bio, Inc. Kusatsu, Japan) were mixed together to prepare a solution with a total volume of 50 ml. A 35-cycle PCR was performed with each cycle run at the following setting: 94 uC for 1 min, 55 uC for 1 min and 72 uC for 2 min. After concentrating the PCR product at 75 uC for 60 min, gel electrophoresis was performed using a 3.0 % agarose gel, and the resulting band patterns were visually categorized.
Repetitive sequence-based PCR (rep-PCR). Rep-PCR was used for automated rep-PCR (DiversiLab; bioMérieux). An UltraClean Microbial DNA isolation kit (MO BIO Laboratories) was used to extract DNA from the cultured colonies and a method adapted for Clostridium recommended by DiversiLab was used. Extracted DNA was adjusted to 50 ng and PCR was performed using a Clostridium fingerprinting kit (DiversiLab). Furthermore, after performing gel electrophoresis using DiversiLab LabChips (bioMérieux) with a 2100 Bioanalyser, the resultant band patterns were analysed using DiversiLab v1.4.
Inspection of the toxin gene. By following the method of Kato et al. (1998) , a colony was resuspended in 100 ml sterile water, heated for 95 uC for 10 min and centrifuged for 10 min at 13 000 g, and the supernatant was then used as a template. Using primers NK104/ NK105, NK11/NK9 and NKV011/NK9, a 36-cycle PCR was performed with each cycle run at the following setting: 94 uC for 1 min, 54 uC for 1 min and 72 uC for 1 min. PCR products were separated by electrophoresis using a 1.5 % agarose gel, and the resulting band pattern was used to categorize samples into A
RESULTS
With two types of MALDI-TOF MS and three identification softwares, the reproducibility of identification was examined using three ATCC strains of C. difficile, 10 times in duplicate with 60 measurements in total. As shown in Table 1 , IVD and Biotyper both demonstrated 100 % reproducibility with high scores (99.9 %, i2.0, respectively). With SARAMIS, the reproducibility remained at 91.7 % with a score i75 %. When a reference spectrum of a strain determined to be closely related to C. difficile was included (Table 2) , the reproducibility was 100 %. Next we examined the identification accuracy using 50 clinical isolates. All the clinical isolates tested could be identified at the species level with IVD or SARAMIS. For Biotyper, only 46 isolates (92 %) were identified, with a score i2.0, and the remaining four strains were identified at the genus level (Tables 1,  2 ). For these four strains (Table 2) , sample preparation and measurements were repeated. Three (samples 8, 21 and 37 in Table 2 ) of these strains showed scores i2.0 and were identified at the species level. However, one sample (sample 35 in Table 2 ) showed scores v2.0. Based on these results, both types of MALDI-TOF MS and all identification softwares demonstrated satisfactory results and were confirmed to be capable of identifying C. difficile accurately.
PCR ribotyping of the 50 clinical isolates enabled categorization into 39 types. The five types that contained multiple strains were ribotype I (two strains), ribotype II (three strains), ribotype III (two strains), ribotype IV (two strains) and ribotype V (seven strains) (Fig. 1a) . When further examined with rep-PCR, ribotypes I-IV were categorized as types A-D. Next, among the seven strains in ribotype V, four belonged to type E and three belonged to type F (Fig. 1b) Table 3 summarizes the results from PCR ribotyping, repetitive sequence-based PCR (rep-PCR) and toxin gene identification. Based on these results, among the 50 clinical isolates, seven strains were confirmed to belong to two types that are closely related. Seven patients from whom these strains were isolated were in the same ward, suggesting transmission within the hospital. The feasibility of C. difficile typing with MALDI-TOF MS was examined by SARAMIS software and Biotyper software. This clustering analysis was based on all MS peaks obtained from VITEK MS and Microflex LT. These results did not agree with those obtained with the typing method based on genetic information (Fig. 2) .
DISCUSSION
For the widespread use of MALDI-TOF MS as a medical device for identifying bacterial species, high sensitivity and specificity are required. Studies on the practical identification accuracy of MALDI-TOF MS began in the 2000s (Demirev et al., 1999) . Currently, two types of MS-based bacterial identification system are available, VITEK MS and Microflex LT. Various studies have been conducted to compare bacterial identification accuracy between these two instruments. Although one study reported the identification accuracy of a variety of bacteria by comparing the two types of instrument across three clinical inspection softwares (IVD, SARAMIS and Biotyper) (Martiny et al., 2012) , to the best of our knowledge no study has assessed C. difficile identification using ATCC reference strains. In this study, we conducted a comparative investigation of the reproducibility of C. difficile identification with three ATCC strains and the identification accuracy with 50 clinical isolates using two types of instrument and three softwares.
When examined by IVD, SARAMIS and Biotyper software, we demonstrated 100, 91.7 and 100 % identification reproducibility of ATCC strains, respectively. A low identification score by SARAMIS was also reported by Martiny et al. (2012) . However, when a reference spectrum of a strain determined to be closely related to C. difficile was included, the reproducibility was 100 %. Therefore, there was no effect on identification reproducibility, whereas identification at the species level was successful. Biotyper failed to identify four isolates on the first measurement. Table 1 .
Reproducibility in identification of Clostridium difficile ATCC strains and identification of 50 clinical isolates by MALDI-TOF MS
The reproducibility of identification was examined using three ATCC strains of C. difficle, 10 times in duplicate with 60 measurements in total. The four isolates (samples 8, 21, 35 and 37 in Table 2 ) that were toxin A 2 B 2 were confirmed to be C. difficile by 16S rRNA sequencing (data not shown). There were no morphological or biochemical differences between the four isolates and the other 46 clinical isolates that were identified successfully on the first measurement. Considering that three of the four isolates provided accurate results by repeating the preparation (Table 2) , any strain that was not identified with confidence as C. difficile should be re-analysed. One of the four isolates was unidentified even on the second analysis. Among toxin A 2 B + isolates, 16 isolates except for the four isolates were identified accurately on the first measurement. This indicates that failure to identify the isolate should not be attributed to the toxin gene type of the four isolates. Some studies have reported that at least 10 reference spectra are typically required for identification with higher accuracy using Microflex LT (Chean et al., 2014; Seng et al., 2009; Veloo et al., 2011) . Therefore, the characteristics of the instrument may affect the identification of the isolate, although operational errors during sample preparation cannot be excluded.
Our results for PCR ribotyping are given as arbitrary clusters A-F because we do not have the reference strains for PCR ribotyping used by Huber et al. (2013) . Using 22 PCR ribotype patterns from the DiversiLab library and the 50 clinical isolates in this study, dendrograms were constructed (data not shown). The DiversiLab library contains 22 ribotype patterns as follows: 001 (two isolates); 002 (two isolates); 005, 010, 012, 014, 015, 020, 023, 027 (three isolates); 053, 056, 078 (three isolates); 097, 106, 110. In regard to the results, cluster C (samples 26 and 36) had 98.3 % similarity to ribotype 014, whereas the remaining isolates did not show high similarity to the other 21 ribotypes. Therefore, we consider that the 50 clinical isolates do not belong to PCR ribotypes 001, 027 or 078, which have recently become globally widespread. Because PCR ribotypes 001, 027 and 078 have not spread to Japan to date (Collins et al., 2013) , our results seem reasonable.
Analysis of C. difficile toxin genes in 50 clinical isolates revealed that 23 strains were toxin A + B + , 7 were toxin A 2 B + , 20 were toxin A 2 B 2 with 19 ribotypes and 23 were toxin A + B + with 19 ribotypes. All seven strains that were toxin A 2 B + had an identical ribotype. rep-PCR results showed that the toxin A 2 B + group consisted of two types; however, these were isolated from the same clinical ward and are suspected to be very closely related. Although we attempted to type C. difficile on the basis of whole-mass spectrum information, the results did not agree with the typing obtained based on genetic *Samples 8, 21, 35 and 37 were confirmed to be C. difficile by 16S rRNA gene sequences (about 1300 bp). For these four isolates, sample preparation and measurements were repeated. Three (samples 8, 21 and 37) of these strains showed scores $2.0 and were identified at the species level. However, one sample (sample 35) showed scores ,2.0.
Evaluation of Clostridium difficile with MALDI-TOF MS
information. It has been reported that some PCR ribotypes can be discriminated using MALDI-TOF MS (Reil et al., 2011) . However, in these cases, ribotype-specific mass signals were extracted prior to the typing instead of using whole-peak information. Therefore, this analysis is possible only for the three types that gave ribotype-specific mass peaks. If appropriate peaks were extracted from mass spectrum data obtained in this study and clustering analysis based on this information was performed, MALDI-TOF MS-based typing results would agree with typing based on genetic information.
In this study, we examined the reproducibility and identification accuracy as well as comparative typing of C. difficile. Although a relatively small number of strains were used for the analysis, both types and all identification softwares demonstrated satisfactory results and were confirmed to be capable of identifying C. difficile accurately. A further large-scale study is required for the accurate comparison of the different MS instruments. Although only a few studies are available regarding the identification of ATCC strains, culturing type, media used and pre-treatments are known to affect the identification accuracy of MALDI-TOF MS C034   C024   C01   C02   C010   C09   C07   C036   2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 Evaluation of Clostridium difficile with MALDI-TOF MS depending on its type (Chean et al., 2014; GrosseHerrenthey et al., 2008; Valentine et al., 2005) . In this study, we did not examine such effects that might have influenced the identification. Although we examined whether typing is possible with the information used for identification, a phylogenetic tree prepared with the appropriate software disagreed with the typing based on genetic information. Because simple and rapid typing with MALDI-TOF MS is considered to be of use for the surveillance of C. difficile infections, this method will require further refinement and optimization in future.
